A calendar that predicts a period and an app marketed for contraception may share some vocabulary. That does not make their intended uses interchangeable. Before relying on a claim about preventing pregnancy, the important question is which exact product, version and indicated use the claim concerns. This is a US product-information distinction, not advice to change contraception.
Read the intended use, not the category name
A description such as 'cycle tracking' does not by itself establish a contraceptive indication. FDA's public birth-control information separately describes medical software applications for contraception and advises discussing the choice of contraception with a healthcare professional. The broad category does not authorize every app that predicts dates.
Preserve the exact maker, product name, version and the claim being made. A screenshot of a colored calendar is not a substitute for those identifiers, and a claim made for a different feature should not be silently extended to the way a reader intends to use it.
A real record shows why precision matters
FDA's De Novo summary DEN170052 identifies Natural Cycles and names software version 3.0 in its software discussion. The indicated-use wording mentions preventing or planning pregnancy, but the summary expressly says its Plan Mode and Pregnancy Mode are outside the scope of this De Novo review. Its contraception discussion concerns Prevent Mode. Those distinctions matter: this is a specific historical record with limitations, warnings and precautions, not authorization of every mode, an arbitrary installed app, sensor combination or later version.
A reader comparing an actual product should therefore ask how its current labeling and version connect to the relevant regulator record. If that connection cannot be established, keep it unresolved. Do not replace it with a brand-level phrase such as 'FDA app' or an assumption based on another person's use.
Separate the record from the personal decision
A simple information comparison can keep three columns: what the promotion says, what the actual product labeling identifies and what the relevant authorization document states. Differences among the columns are questions for the provider or an appropriate healthcare professional, not opportunities to improvise a method.
FDA's materials also make clear that contraceptive software has limitations and is not a universal choice. No efficacy percentage, cycle interpretation or personal eligibility decision is supplied here. Do not stop an established method or substitute a general period tracker on the basis of this article.
Keep the next question specific
The useful question is 'Does this exact product and version have this intended use, under these stated conditions?' That is more informative than asking whether apps in general work. The product-information check can support a professional conversation; it cannot make the contraceptive decision for the person who will use it.
Sources & further reading
Published sources for the details and examples discussed in this story.
